2016
DOI: 10.1016/j.vaccine.2016.09.048
|View full text |Cite
|
Sign up to set email alerts
|

Commercial vaccines provide limited protection to NADC30-like PRRSV infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
56
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 71 publications
(60 citation statements)
references
References 15 publications
3
56
1
Order By: Relevance
“…PRRSV is one of the most important viruses hindering the development of the swine industry globally, especially with the emergence of highly pathogenic PRRSV (HP-PRRSV) [5,38]. Recently, new PRRSV mutant strains have become pandemic in China [1,16,17,35,37,39] and are named NADC30-like PRRSV strains for their genomic similarity to the NADC30 strain isolated in the US in 2008 [3]. NADC30-like PRRSV strains feature different recombinations and have produced many mosaic isolates, enhancing their genetic diversity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…PRRSV is one of the most important viruses hindering the development of the swine industry globally, especially with the emergence of highly pathogenic PRRSV (HP-PRRSV) [5,38]. Recently, new PRRSV mutant strains have become pandemic in China [1,16,17,35,37,39] and are named NADC30-like PRRSV strains for their genomic similarity to the NADC30 strain isolated in the US in 2008 [3]. NADC30-like PRRSV strains feature different recombinations and have produced many mosaic isolates, enhancing their genetic diversity.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to genetic mutation, PRRSV genetic diversity is also generated by recombination among different strains, including vaccine strains [7,18,23,30,33,37]. Importantly, commercial vaccines cannot provide complete protection against heterologous PRRSV infection [1,21]. The problems outlined above indicate that the use of vaccines may not be an ideal strategy for PRRSV control; however, exploring effective anti-PRRSV drugs may overcome these issues.…”
Section: Introductionmentioning
confidence: 99%
“…The coexistence of distinct PRRSV isolates in Chinese swine herds makes it very complicate to effectively prevent and control the diseases. Commercial PRRSV modified live vaccines (MLV) may provide satisfied protection against homologous PRRSV infection; however, the cross‐protection against heterologous PRRSV infection is very limited (Bai et al, ; Renukaradhya, Meng, Calvert, Roof, & Lager, ; Zhou et al, ). Therefore, reliable and convenient differential detection method is crucial to adopt effective control strategies such as the selection of phylogenetically related vaccines.…”
Section: Discussionmentioning
confidence: 99%
“…HP‐PRRSV2 isolates generally have the highest virulence followed by the NL‐PRRSV2 and CA‐PRRSV2 isolates (Li et al, ; Sun et al, ; Tian et al, ), while current Chinese PRRSV1 isolates are low virulent (Chen et al, ; Ming et al, ). In addition, commercial PRRSV vaccines provide limited cross‐protection against different genotypes/subtypes of PRRSV infection (Bai et al, ; Zhou et al, ). The coexistence of distinct PRRSV in Chinese swine herds makes it more complicated to combat PRRSV infection.…”
Section: Introductionmentioning
confidence: 99%
“…In 1996, PRRSV was first isolated in mainland China and was named as CH‐1a (Guo, Chen, Liu, & Cui, ). In 2006, a highly pathogenic PRRS (HP‐PRRS) induced by a variant PRRSV emerged in China, which caused great losses to the pig industry (An et al., ; Bai et al., ; Guo et al., ; Li et al., ; Tian et al., ; Tong et al., ). At present, variation and diversity of PRRSV has become a large threat for the global pig industry.…”
Section: Introductionmentioning
confidence: 99%